Ultracytech: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Ultracytech
Largest movements
- Cash -€70,699
down €70,699 (-68.5%), from €103,136 to €32,437
mainly Other debts (-€59,619) and Deferred charges and accrued income (-€17,483)
- Deferred charges and accrued income +€17,483
up €17,483 (+1246.4%), from €1,403 to €18,886
- Receivables within one year -€9,625
down €9,625 (-39.1%), from €24,614 to €14,989
of which Trade receivables: -€10,548
- Other debts -€59,619
down €59,619 (-49.1%), from €121,524 to €61,904
- Tax, wage and social debts -€4,503
down €4,503 (-65.2%), from €6,909 to €2,406
- Gross operating margin -€40,781
down €40,781 (-61.0%), from €66,851 to €26,070
- Taxes -€9,923
down €9,923 (-64.1%), from €15,484 to €5,561
- Financial charges -€1,616
down €1,616 (-79.1%), from €2,043 to €428
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €133,716 | €69,742 | -€63,974 | -47.8% |
| Fixed assets | 21/28 | €4,563 | €3,430 | -€1,133 | -24.8% |
| Tangible fixed assets | 22/27 | €4,563 | €3,430 | -€1,133 | -24.8% |
| Furniture and vehicles | 24 | €4,563 | €3,430 | -€1,133 | -24.8% |
| Current assets | 29/58 | €129,153 | €66,312 | -€62,841 | -48.7% |
| Amounts receivable within one year | 40/41 | €24,614 | €14,989 | -€9,625 | -39.1% |
| Trade receivables | 40 | €24,598 | €14,050 | -€10,548 | -42.9% |
| Other amounts receivable | 41 | €16 | €939 | +€923 | +5610.6% |
| Cash at bank and in hand | 54/58 | €103,136 | €32,437 | -€70,699 | -68.5% |
| Deferred charges and accrued income | 490/1 | €1,403 | €18,886 | +€17,483 | +1246.4% |
| Total equity and liabilities | 10/49 | €133,716 | €69,742 | -€63,974 | -47.8% |
| Equity | 10/15 | €2,000 | €2,000 | = | 0.0% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Amounts payable | 17/49 | €131,716 | €67,742 | -€63,974 | -48.6% |
| Amounts payable within one year | 42/48 | €131,716 | €67,742 | -€63,974 | -48.6% |
| Trade debts | 44 | €3,283 | €3,432 | +€149 | +4.5% |
| Suppliers | 440/4 | €3,283 | €3,432 | +€149 | +4.5% |
| Taxes, remuneration and social security | 45 | €6,909 | €2,406 | -€4,503 | -65.2% |
| Taxes | 450/3 | €6,909 | €2,406 | -€4,503 | -65.2% |
| Other amounts payable | 47/48 | €121,524 | €61,904 | -€59,619 | -49.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,179 | €2,761 | +€582 | +26.7% |
| Other operating charges | 640/8 | €1,084 | €1,283 | +€198 | +18.3% |
| Gross operating margin | 9900 | €66,851 | €26,070 | -€40,781 | -61.0% |
| Operating profit (loss) | 9901 | €63,588 | €22,026 | -€41,562 | -65.4% |
| Financial income | 75/76B | €0 | - | -€0 | |
| Recurring financial income | 75 | €0 | - | -€0 | |
| Financial charges | 65/66B | €2,043 | €428 | -€1,616 | -79.1% |
| Recurring financial charges | 65 | €2,043 | €428 | -€1,616 | -79.1% |
| Profit (loss) for the period before taxes | 9903 | €61,544 | €21,598 | -€39,946 | -64.9% |
| Income taxes | 67/77 | €15,484 | €5,561 | -€9,923 | -64.1% |
| Profit (loss) for the period | 9904 | €46,061 | €16,038 | -€30,023 | -65.2% |
| Profit (loss) for the period to be appropriated | 9905 | €46,061 | €16,038 | -€30,023 | -65.2% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 1 October 2026 via checked.be.